We then characterized the breast tumors according to the four major molecular subgroups, i.e., luminal A (n = 216), luminal B (n = 121), ERBB2 (n = 44), and triple-negative tumors (n = 67) [36]. Here, ERBB2 is linked to breast neoplasm.